A connected therapeutics company has received 510(k) clearance from the U.S. Food and Drug Administration for a physician-driven dosage management platform for basal insulin geared for Type 2 diabetes ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes reached their optimal basal insulin dose in 15 days with use of an artificial ...

Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers.* Dexcom Smart Basal is FDA cleared and now the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with type 2 diabetes improved time in range after ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to fasting blood glucose levels. A fixed-dose regimen of insulin efsitora alfa ...

If you’re taking basal insulin therapy, your treatment approach will be different from others with type 2 diabetes. Even if you’ve been taking this type of insulin for a long time, it’s good to remind ...

You can manage type 2 diabetes several ways, including with a healthy diet and regular exercise. But sometimes, you may need insulin and other medication to help control your blood sugar levels. The ...

March 19, 2010 — Basal insulin requirements may be less on the day after maintenance hemodialysis in type 2 diabetic patients with end-stage renal disease, according to the results of a study reported ...

Use of Mealtime SYMLIN Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin Results from a 24-week multi-center, randomized, ...

When you first receive a type 2 diabetes diagnosis, your doctor may start you on lifestyle modifications like diet and exercise. Or you may begin taking an oral medication like metformin. Yet ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III QWINT development program found. In QWINT-1, there was a similar ...